EGF receptor-targeted therapy in non-small-cell lung cancer: role of germline polymorphisms in outcome and toxicity.
about
Clinical advances in molecular biomarkers for cancer diagnosis and therapyAKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients.Mechanisms behind the inhibition of lung adenocarcinoma cell by shikoninExpression of the receptor for advanced glycation end-products and frequency of polymorphism in lung cancer.Class act: safety comparison of approved tyrosine kinase inhibitors for non-small-cell lung carcinoma.Role of polymer-drug conjugates in organ-specific delivery systems.A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer.Design and synthesis of quinazolinone tagged acridones as cytotoxic agents and their effects on EGFR tyrosine kinase.Shikonin enhances Adriamycin antitumor effects by inhibiting efflux pumps in A549 cells.[Effects of EGFR gene polymorphisms on efficacy and prognosis in advanced non-small cell lung cancer treated with EGFR-TKIs].
P2860
Q27027560-E5CCA089-0BAE-40C2-BF17-631DD8FAE65CQ34215987-F7441CF0-FCC1-4401-8717-9858F513BBDCQ34277873-CE669E60-D962-464A-9477-9967B0B3F7A1Q35803624-ABFBA265-FE87-4F03-9AF6-1A4B5155C3C5Q38262804-DA7D62F5-04E2-493E-8DF4-9DA7C9586435Q38365556-220D7B7C-3A90-4B01-A31C-B7147C00B974Q38806879-D05F9C27-D07C-4BB0-81DE-4569DFD88B8CQ38991074-84EEDE56-FD06-4456-BE2C-C98510EB0B96Q41701853-CE6CCBFD-3FFB-4572-9C86-A7D523EFF532Q44919323-38EE6F4E-94CC-49EE-BD79-5091F5D85B81
P2860
EGF receptor-targeted therapy in non-small-cell lung cancer: role of germline polymorphisms in outcome and toxicity.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
EGF receptor-targeted therapy ...... hisms in outcome and toxicity.
@en
type
label
EGF receptor-targeted therapy ...... hisms in outcome and toxicity.
@en
prefLabel
EGF receptor-targeted therapy ...... hisms in outcome and toxicity.
@en
P2860
P356
P1433
P1476
EGF receptor-targeted therapy ...... hisms in outcome and toxicity.
@en
P2093
Elena Galvani
Godefridus J Peters
P2860
P304
P356
10.2217/FON.12.89
P407
P577
2012-08-01T00:00:00Z